Workflow
CITIC Securities Co., Ltd.(600030)
icon
Search documents
中信证券:2026年春节白酒实际动销有望维持平稳 看好行业底部配置机会
人民财讯1月23日电,中信证券研报称,白酒行业即将迎来春节旺季营销活动,渠道在经销商大会后持 续学习吸收龙头企业进行的渠道、产品等多维度改革经验。行业或在新改革和新方向下重新聚焦市场培 育和消费者教育,促进开瓶动销并为经销商减负。综合考虑到动销已逐步平稳、2026年春节假期多一 天、白酒春节消费场景等诸多因素,判断2026年春节白酒实际动销有望维持平稳,无须过度悲观。再考 虑到后续逐步复苏趋势明确,看好白酒行业底部配置机会。预计2026年啤酒行业将在底部位置温和复 苏,建议关注渠道控制力强、具备品牌溢价能力的行业龙头。 ...
中信证券:建议当前核心围绕先进封装和存储封装环节进行布局
Di Yi Cai Jing· 2026-01-23 00:34
Core Viewpoint - The report from CITIC Securities indicates that due to rising raw material prices and increased demand for AI and storage, a new round of price increases in packaging is expected to begin, with advanced packaging market attention likely to rise driven by domestic computing power demand [1] Group 1: Market Trends - Rising raw material prices are influencing the packaging industry [1] - Increased demand for AI and storage is contributing to market dynamics [1] - The advanced packaging market is expected to gain more attention [1] Group 2: Investment Recommendations - The company suggests focusing on advanced packaging and storage packaging segments for investment opportunities [1]
中信证券:考虑到后续逐步复苏趋势明确,看好白酒行业底部配置机会
Xin Lang Cai Jing· 2026-01-23 00:34
中信证券研报指出,白酒行业即将迎来春节旺季营销活动,渠道在经销商大会后持续学习吸收龙头企业 进行的渠道、产品等多维度改革经验。我们认为,行业或在新改革和新方向下重新聚焦市场培育和消费 者教育,促进开瓶动销并为经销商减负。综合考虑到动销已逐步平稳、2026年春节假期多一天、白酒春 节消费场景等诸多因素,我们判断2026年春节白酒实际动销有望维持平稳,无须过度悲观。再考虑到后 续逐步复苏趋势明确,看好白酒行业底部配置机会。预计2026年啤酒行业将在底部位置温和复苏,建议 关注渠道控制力强、具备品牌溢价能力的行业龙头。 ...
2025年度Wind最佳投行评选结果隆重揭晓
Wind万得· 2026-01-23 00:13
2025年度"Wind最佳投行"评选结果于2026年1月23日隆重揭晓!秉承公正与透明的核心理念,万得依托全面、客观的市场数据,对各大机构在股 权、债券及并购交易等各资本市场核心领域的承销实力进行了系统评估。评选过程综合了2025年度万得A股股权承销榜、港股股权承销榜、中国市 场并购交易排行榜、债券承销榜、ABS承销榜和中资美元债承销榜的各项数据,同时充分采纳相关机构在排行榜发布后的反馈与核实修正,最终呈 现出第七届"Wind最佳投行"的获奖名单。共计一百余家机构凭借卓越表现斩获荣誉,彰显其在资本市场的非凡实力与贡献。 该评选旨在以准确、客观的评价,全面展现中国证券市场各家机构的发行与承销能力,并向致力于推动中国资本市场稳健发展的卓越机构致以崇高敬意! 1 中信证券 1 2 (D 国泰海通 3 0 中金公司 华泰联合证券 4 1 中信建投 5 用数据说话 / 无主观投票 Win.d 最佳投行 2025 年度 Wind 结果重磅 洗 股 揭 it 最佳股权承销商 Wind最佳投行榜单 最佳A股股权承销商 1 2 中信证券 国泰海通 3 中银证券 4 中金公司 华泰联合证券 5 中信建投 6 7 广发证券 申万宏 ...
券商业绩预喜,股价为何滞涨?
Guo Ji Jin Rong Bao· 2026-01-22 15:41
Core Viewpoint - The brokerage sector's performance has significantly lagged behind the overall market, with a mere 6% increase in the brokerage concept index compared to over 18% gains in major indices like the Shanghai Composite Index in 2025, despite a more than 60% year-on-year increase in net profits for 42 listed brokerages [1][3]. Group 1: Performance Discrepancy - The brokerage concept index underperformed the market, with a 6% increase compared to over 18% for the Shanghai Composite Index and nearly 50% for the ChiNext Index [3]. - Despite a strong year-on-year growth of over 60% in net profits for listed brokerages, their stock prices have not reflected this performance, indicating a stark divergence between earnings and market valuation [3][4]. Group 2: Reasons for Underperformance - The brokerage sector's stock prices often move ahead of actual earnings, leading to a situation where the market has already priced in future growth, resulting in profit-taking when actual results are released [4]. - A structural shift in the A-share market has favored high-growth sectors like technology, causing funds to flow away from traditional cyclical stocks like brokerages, which are perceived as lacking short-term explosive growth narratives [4][5]. - The cyclical and fragile nature of brokerage earnings, heavily reliant on market volatility and trading activity, has diminished their growth appeal, with a significant portion of revenue tied to self-operated businesses [4][5]. Group 3: Investor Sentiment and Strategy - Investors are advised to remain patient and not to rush into buying brokerage stocks without clear catalysts, such as a shift in fund flows back to undervalued cyclical stocks or favorable policy developments [9]. - For investors currently holding brokerage stocks, it is suggested to assess the fundamentals and consider holding or gradually increasing positions in well-capitalized, leading brokerages while being cautious with smaller firms [8][9]. - New investors should focus on long-term trends in the brokerage industry, including financial technology applications and international business expansion, while being selective about which stocks to invest in [9].
中信证券贾祎樊:看好服务器电源、超级电容等方向投资机会
Zhong Zheng Wang· 2026-01-22 14:40
Core Viewpoint - The AI wave is expected to widen the power gap, leading to transformative changes in the IDC (Internet Data Center) power systems, with a positive outlook on the market share of domestic server power brands and investment opportunities arising from capacity shortages and product iterations in new products like supercapacitors and SST (Solid State Transformers) [1] Group 1: AI Impact on Power Demand - The demand for power equipment, particularly in North America, is experiencing steep growth driven by AI electricity consumption [1] - The increase in online electricity prices on the supply side presents investment opportunities in SMR (Small Modular Reactors) [1] Group 2: Evolution of Power Systems - The transition of UPS (Uninterruptible Power Supply) towards a fully DC system is underway, with continuous increases in output voltage levels [1] - The rise in power density of server power supplies is expected to lead to simultaneous increases in both product volume and price, potentially driving demand for supercapacitors [1]
华峰测控:关于中信证券股份有限公司对科创板股票华峰测控开展做市交易业务的公告
(编辑 丛可心) 证券日报网讯 1月22日,华峰测控发布公告称,根据《上海证券交易所科创板股票做市交易业务实施细 则》相关规定,经中信证券股份有限公司备案申请,自2026年1月23日起,中信证券股份有限公司对科 创板股票华峰测控(股票代码:688200)开展做市交易业务。 ...
上海燧原科技股份有限公司IPO获上交所受理
Jing Ji Guan Cha Wang· 2026-01-22 12:18
经济观察网2026年1月22日,上交所官网披露了上海燧原科技股份有限公司首次公开发行股票招股说明 书(申报稿),公司IPO材料被正式受理。根据招股书,上海燧原科技股份有限公司拟于上海证券交易所 科创板上市,保荐机构为中信证券股份有限公司,本次拟公开发行新股不低于4,303.52万股且不超过 6,835.00万股,占发行后总股本比例不低于10%且不超过15%。 ...
普祺医药递表港交所,中信证券和民银资本担任联席保荐人
Cai Jing Wang· 2026-01-22 11:43
(港交所官网披露易) (编辑:杨燕 林辰) 近日,普祺医药向香港联交所主板递交上市申请书,中信证券和民银资本担任联席保荐人。 普祺医药是一家专注于免疫炎症领域的生物科技公司,普美昔替尼凝胶为用于治疗特应性皮炎的JAK抑 制剂凝胶,已完成成人及12至17岁青少年特应性皮炎适应症的III期临床试验,并正拓展至2至11岁儿童 特应性皮炎。普美昔替尼鼻喷雾剂为全球首款用于治疗季节性过敏性鼻炎的临床阶段JAK抑制剂鼻喷雾 剂,正处于针对成年人季节性过敏性鼻炎的III期临床试验阶段,并正拓展至青少年季节性过敏性鼻炎及 成年人常年性过敏性鼻炎。 ...
关于同意中信证券股份有限公司为天弘上证科创板芯片设计主题交易型开放式指数证券投资基金提供主做市服务的公告
Xin Lang Cai Jing· 2026-01-22 09:57
上证公告(基金)【2026】115号 为促进天弘上证科创板芯片设计主题交易型开放式指数证券投资基金(以下简称科芯TH,基金代 码:589070)的市场流动性和平稳运行,根据《上海证券交易所基金自律监管规则适用指引第2号——上 市基金做市业务》等相关规定,本所同意中信证券股份有限公司自2026年01月23日起为科芯TH提供主 做市服务。 特此公告。 上海证券交易所 2026年01月22日 ...